The FDA has approved a Genentech drug meant to prevent or reduce bleeding in hemophilia A patients who have developed an immune response to currently available treatments for the condition.
But Thursday’s approval of emicizumab-kxwh (Hemlibra) comes with a warning about... Read more »
The researchers and doctors at Seattle Children’s are embarking upon a complicated quest, involving multiple clinical studies of cutting-edge CAR-T cell therapies, to help kids and young adults with an aggressive form of leukemia. As of today, one key part of... Read more »
Lessonly, the Indianapolis-based startup focused on team training software, this week announced it has raised an $8 million Series B funding round. Led by Boston’s OpenView Partners, the round also drew contributions from Rethink Education, High Alpha Capital... Read more »
A little over a year after Understory began working with Pacific Specialty Insurance Company, the two organizations are now announcing a collaboration aimed at lowering the amount of money insurers pay policyholders for weather-related property damage.
Madison, WI-based Understory, a... Read more »
What’s new in San Diego life sciences?
Diego Miralles, who was named just three months ago as the CEO of San Diego-based Vividion Therapeutics, has a lot to say on that topic. Miralles, an immunologist who previously served as the CEO... Read more »
When it comes to consumer robotics, iRobot has to be the poster child. It was born 27 years ago out of MIT, founded by legendary roboticist Rodney Brooks, now professor emeritus, and two of his students, Helen Greiner and Colin Angle.... Read more »
[Updated 11/16/17, 10:47 am. See below.] Dave Balter, a serial entrepreneur and startup investor in the Boston area, has stepped down as CEO of one of his latest ventures, Mylestone.
Balter has shifted to the role of chairman, and... Read more »
The immune system can’t fight disease if its cells don’t reach their targets. In some cancers and rare immune deficiency disorders, immune cell levels are too low. X4 Pharmaceuticals has developed drugs that it says can help restore these counts to... Read more »
When automotive supplier Delphi forked over approximately $450 million to buy Boston-based software startup NuTonomy last month, it was the latest in a spate of high-dollar acquisitions involving companies that develop self-driving technologies. NuTonomy, founded by MIT researchers, was only four... Read more »